JP2015071583A5 - - Google Patents

Download PDF

Info

Publication number
JP2015071583A5
JP2015071583A5 JP2014060235A JP2014060235A JP2015071583A5 JP 2015071583 A5 JP2015071583 A5 JP 2015071583A5 JP 2014060235 A JP2014060235 A JP 2014060235A JP 2014060235 A JP2014060235 A JP 2014060235A JP 2015071583 A5 JP2015071583 A5 JP 2015071583A5
Authority
JP
Japan
Prior art keywords
active ingredient
soybean lecithin
food
atrodin
muscle atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014060235A
Other languages
Japanese (ja)
Other versions
JP2015071583A (en
JP6374682B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2014060235A priority Critical patent/JP6374682B2/en
Priority claimed from JP2014060235A external-priority patent/JP6374682B2/en
Publication of JP2015071583A publication Critical patent/JP2015071583A/en
Publication of JP2015071583A5 publication Critical patent/JP2015071583A5/ja
Application granted granted Critical
Publication of JP6374682B2 publication Critical patent/JP6374682B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (4)

大豆レシチンを有効成分とするアトロジン−１発現抑制剤。   An atrodin-1 expression inhibitor comprising soybean lecithin as an active ingredient. 大豆レシチンを有効成分とする筋萎縮抑制剤。   A muscle atrophy inhibitor comprising soybean lecithin as an active ingredient. 大豆レシチンを有効成分とするアトロジン−１発現抑制用食品又は食品組成物。 A food or food composition for suppressing expression of atrodin-1 comprising soybean lecithin as an active ingredient . 大豆レシチンを有効成分とする筋萎縮抑制用食品又は食品組成物。 A food or food composition for inhibiting muscle atrophy comprising soybean lecithin as an active ingredient .
JP2014060235A 2013-09-09 2014-03-24 Muscle atrophy inhibitor Active JP6374682B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014060235A JP6374682B2 (en) 2013-09-09 2014-03-24 Muscle atrophy inhibitor

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013185976 2013-09-09
JP2013185976 2013-09-09
JP2014060235A JP6374682B2 (en) 2013-09-09 2014-03-24 Muscle atrophy inhibitor

Publications (3)

Publication Number Publication Date
JP2015071583A JP2015071583A (en) 2015-04-16
JP2015071583A5 true JP2015071583A5 (en) 2017-03-02
JP6374682B2 JP6374682B2 (en) 2018-08-15

Family

ID=53014251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014060235A Active JP6374682B2 (en) 2013-09-09 2014-03-24 Muscle atrophy inhibitor

Country Status (1)

Country Link
JP (1) JP6374682B2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1277467B1 (en) * 1991-06-10 2006-09-20 Schering Corporation Non-chlorofluorocarbon aerosol formulations
JP4739161B2 (en) * 2005-10-26 2011-08-03 花王株式会社 Endurance improver
JP2008013473A (en) * 2006-07-05 2008-01-24 Kao Corp Muscle hypofunction inhibitor
US8877239B2 (en) * 2010-08-12 2014-11-04 Nutritional Therapeutics, Inc. Lipid supplements for maintaining health and treatment of acute and chronic disorders
JP5922863B2 (en) * 2010-02-03 2016-05-24 花王株式会社 Motor function improver
CA2792137C (en) * 2010-03-24 2020-03-10 Medesis Pharma Reverse micelle system comprising nucleic acids and use thereof

Similar Documents

Publication Publication Date Title
PT3565550T (en) Pharmaceutical compositions comprising meloxicam
IL247836B (en) 1,3- benzodioxole derivatives, compositions comprising same and uses thereof
IL248264B (en) 5-oxy-pyridazin-3-one derivatives and herbicidal compositions comprising them
EP3432870A4 (en) Compositions comprising choline
EP3371152A4 (en) Compositions comprising an inhibitor of lysine specific demethylase-1
IL269803A (en) 6-pyrimidin-isoindole derivative as erk1/2 inhibitor
AU2020273281B2 (en) Therapeutic uses of ibogaine and related compounds
IL252828A0 (en) Piperidine derivative hdac1/2 inhibitor compounds, compositions comprising same and uses thereof
DK3103453T3 (en) MEDICAL COMPOSITION COMPREHENSIVE Heterocyclic DIAMINO-CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT
EP3193854A4 (en) Eutectic formulations of cyclobenzaprine hydrochloride
IL248785B (en) N-[1,5-dimethyl-3-oxo-(2,3-dihydro-1h-pyrazol-4-yl)]-4-methyl-isoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising said derivatives
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
MA49837A (en) PHARMACEUTICAL COMPOSITIONS
HK1254573A1 (en) Pharmaceutical compositions comprising phenylaminopyrimidine derivative
IL304109A (en) Pharmaceutical compositions comprising safinamide
IL248773B (en) 1,6-naphthyridine-4,5-dione derivatives and pharmaceutical compositions comprising them
HK1243927A1 (en) Composition containing theasapogenol derivative as active ingredient
IL266833B (en) Compositions for organ preservation
EP3199530A4 (en) Benzofuran analogue as ns4b inhibitor
EP3256138A4 (en) Pharmaceutical compositions comprising meloxicam
EP3216452A4 (en) Composition for preventing or treating mucositis comprising necrox as effective ingredient
JP2015071583A5 (en)
MA49625A (en) PHARMACEUTICAL COMPOSITIONS
JP2015071584A5 (en)
EP3120848A4 (en) Therapeutic/preventive agent containing coumarin derivative as active ingredient